Jane Ph D Hsiao insider trades: Opko Health (OPK) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jane reports to the SEC






and 11 more companies
Open-market buys and sales
40 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 17, 2024 | OPK | ↑ Buy | 150,000 | $0.95 | $143K | Direct | Jan 17, 2024 (0d) |
| Jan 5, 2024 | OPK | ↑ Buy | 150,010 | $0.87 | $131K | Direct | Jan 8, 2024 (3d) |
| Nov 10, 2023 | OPK | ↑ Buy | 100,000 | $1.27 | $127K | Direct | Nov 13, 2023 (3d) |
| Aug 9, 2021 | OPK | ↑ Buy | 10 | $3.73 | $37 | Direct | Aug 10, 2021 (1d) |
| Oct 25, 2019 | OPK | ↑ Buy | 400,000 | $1.50 | $600K | Indirect | Oct 25, 2019 (0d) |
| May 9, 2019 | OPK | ↑ Buy | 10,000 | $2.03 | $20K | Direct | May 10, 2019 (1d) |
| Dec 21, 2018 | NIMU | ↑ Buy | 20,883,660 | $0.07 | $1.5M | Indirect | Dec 27, 2018 (6d) |
| Dec 21, 2018 | NIMU | ↑ Buy | 6,352,074 | $0.07 | $445K | Direct | Dec 27, 2018 (6d) |
| May 11, 2017 | OPK | ↑ Buy | 20,000 | $6.92 | $139K | Direct | May 12, 2017 (1d) |
| May 10, 2017 | OPK | ↑ Buy | 40,000 | $6.97 | $279K | Direct | May 11, 2017 (1d) |
| Mar 17, 2016 | OPK | ↑ Buy | 1,200 | $10.65 | $13K | Direct | Mar 18, 2016 (1d) |
| Mar 16, 2016 | OPK | ↑ Buy | 1,200 | $9.99 | $12K | Direct | Mar 17, 2016 (1d) |
| Mar 15, 2016 | COCP | ↑ Buy | 1,235,294 | $0.51 | $630K | Direct | Mar 17, 2016 (2d) |
| Mar 15, 2016 | OPK | ↑ Buy | 2,400 | $10.06 | $24K | Direct | Mar 16, 2016 (1d) |
| Mar 11, 2016 | OPK | ↑ Buy | 1,200 | $10.21 | $12K | Direct | Mar 15, 2016 (4d) |
| Mar 10, 2016 | OPK | ↑ Buy | 3,600 | $9.94 | $36K | Direct | Mar 15, 2016 (5d) |
| Aug 25, 2015 | OPK | ↑ Buy | 20,000 | $10.82 | $216K | Direct | Aug 26, 2015 (1d) |
| Mar 25, 2015 | COCP | ↑ Buy | 2,200,000 | $0.92 | $2.0M | Direct | Mar 27, 2015 (2d) |
| Apr 15, 2014 | OPK | ↑ Buy | 10,000 | $8.03 | $80K | Direct | Apr 15, 2014 (0d) |
| Jan 31, 2014 | OPK | ↑ Buy | 10,000 | $7.96 | $80K | Direct | Feb 5, 2019 (1831d) |
| Jan 30, 2014 | OPK | ↑ Buy | 10,000 | $8.14 | $81K | Direct | Jan 31, 2014 (1d) |
| Jan 28, 2014 | OPK | ↑ Buy | 10,000 | $8.20 | $82K | Direct | Jan 30, 2014 (2d) |
| Apr 8, 2013 | NIMU | ↑ Buy | 20,000,000 | $0.05 | $1.0M | Direct | Apr 10, 2013 (2d) |
| Apr 3, 2013 | OPK | ↑ Buy | 5,000 | $6.99 | $35K | Direct | Apr 4, 2013 (1d) |
| Mar 22, 2013 | SFES.OB | ↑ Buy | 4,000,000 | $0.25 | $1.0M | Direct | Mar 26, 2013 (4d) |
| Oct 9, 2012 | OPK | ↑ Buy | 10,000 | $4.34 | $43K | Direct | Oct 10, 2012 (1d) |
| Jul 30, 2012 | OPK | ↑ Buy | 50,000 | $4.33 | $217K | Indirect | Feb 5, 2019 (2381d) |
| Mar 29, 2012 | OPK | ↑ Buy | 10,000 | $4.70 | $47K | Direct | Mar 30, 2012 (1d) |
| Feb 28, 2012 | NIMU | ↑ Buy | 6,000,000 | $0.05 | $300K | Direct | Mar 1, 2012 (2d) |
| Feb 17, 2012 | SFES | ↑ Buy | 4,500,000 | $0.40 | $1.8M | Direct | Feb 22, 2012 (5d) |
| Oct 5, 2011 | OPK | ↑ Buy | 1,200,000 | $3.60 | $4.3M | Indirect | Oct 5, 2011 (0d) |
| Jan 21, 2011 | OPK | ↑ Buy | 200,000 | $3.55 | $710K | Indirect | Jan 25, 2011 (4d) |
| Jun 15, 2010 | SFES.OB | ↑ Buy | 1,300,000 | $1.00 | $1.3M | Hsu Gamma Investments, L.P. | Jun 17, 2010 (2d) |
| Jul 27, 2009 | OPK | ↑ Buy | 10,000 | $1.75 | $18K | Indirect | Jul 27, 2009 (0d) |
| Jul 2, 2008 | OPK | ↑ Buy | 53,000 | $1.31 | $70K | Indirect | Jul 7, 2008 (5d) |
| May 28, 2008 | SFES | ↑ Buy | 60,000 | $2.15 | $129K | Hsu Gamma Investment, L.P. | May 29, 2008 (1d) |
| May 8, 2008 | OPK | ↑ Buy | 500,000 | $1.25 | $625K | Indirect | May 12, 2008 (4d) |
| Feb 11, 2008 | OPK | ↑ Buy | 2,000,000 | $1.80 | $3.6M | Indirect | Feb 13, 2008 (2d) |
| Dec 4, 2007 | OPK | ↑ Buy | 4,076,087 | $1.84 | $7.5M | Direct | Dec 6, 2007 (2d) |
| Jul 13, 2007 | OPK | ↑ Buy | 1,000,000 | $1.80 | $1.8M | Direct | Jul 16, 2007 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OPK insiders
Open-market trades in the last 12 months
About Jane Ph D Hsiao's insider trades
Jane Ph D Hsiao is Vice Chairman & CTO at Opko Health (OPK). Since Jul 13, 2007, Jane has reported 40 open-market purchases worth $31.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (58 filings), option exercises (13 filings), other transactions (6 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.